Business
AstraZeneca expects COVID variant vaccine by mid to late 2021 – Al Jazeera English
The drug company says it expects an updated COVID-19 vaccine targeting new variants to be ready for use this year.
AstraZeneca has said it expects to have a new version of its COVID-19 vaccine ready for use by mid to late 2021, responding to concerns about emerging variants of the disease that may be more transmissible or resistant to existing vaccines.
The Anglo-Swedish company, which makes a vaccine developed by the University of Oxford, said on Thursday that researchers began the work on the updates months ago when the new variants were first detected.
Were moving fast and weve got a number of variant versions…
-
Noosa News7 hours agoMan charged over allegedly abandoning Arnie the German shepherd in car after claiming dog and vehicle were stolen
-
Noosa News8 hours agoMotorcyclist dies in crash with truck
-
Noosa News23 hours agoPolice officer who tracked Toyah Cordingley’s phone gives evidence at Rajwinder Singh’s murder trial
-
General14 hours agoSmall-town cleaner finds himself in legal battle with EnduroShield over product packaging